ENG/中
老虎证券
行情
交易
收费
下载
优惠与活动
帮助
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
股权激励
关于
登录
立即注册
Toggle
澳股
详情
本页面由Tiger Trade Technology Pte. Ltd.提供服务
ALGORAE PHARMACEUTICALS LTD
0.016
+0.001
6.67%
成交量：
118.09万
成交额：
1.80万
市值：
2,720.80万
市盈率：
-26.36
高：
0.016
开：
0.015
低：
0.015
收：
0.015
52周最高：
0.024
52周最低：
0.005
股本：
17.00亿
流通股本：
10.47亿
量比：
8.51
换手率：
0.11%
股息：
- -
股息率：
- -
每股收益(TTM):
-0.001
每股收益(LYR):
0.000
净资产收益率：
-47.38%
总资产收益率：
-39.62%
市净率：
14.40
市盈率(LYR):
-32.06
数据加载中...
总览
公司
新闻资讯
公告
Algorae制药公司达成协议 将在澳大利亚和新西兰推出两款心血管及代谢疾病仿制药
美股速递
·
02/09
Algorae Pharmaceuticals - 签署协议向澳大利亚市场供应化疗药物卡培他滨
美股速递
·
2025/11/27
Algorae Pharmaceuticals - 拟议协议下，公司将在澳新市场推出两款仿制药及其他产品
美股速递
·
2025/10/20
Algorae Pharmaceuticals达成协议，将5款仿制肿瘤药物推向澳大利亚和新西兰市场
美股速递
·
2025/09/23
{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券 | 轻松买卖美股港股A股/美债/ETF/Crypto/期权期货","description":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","keywords":"老虎证券,老虎证券开户,老虎证券香港,老虎证券登录,老虎证券官网,香港证券开户,证券公司开户,股票开户,香港证券公司,香港证券,证券公司,股票投资,投资app,投资平台,股票买卖,股票交易平台,股票app,证券app,新手投资","social":{"ogDescription":"老虎证券提供多项优惠：港股&Crypto 0佣、A股通一年免佣、美股期权0佣、IPO打新0融资利息0手续费。 美股1美元起投，免费实时行情与多种工具，立即开户享更多优惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/1AI.AU/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"1AI.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","market":"AU","secType":"STK","nameCN":"ALGORAE PHARMACEUTICALS LTD","latestPrice":0.016,"timestamp":1774309678619,"preClose":0.015,"halted":0,"volume":1180920,"delay":0,"changeRate":0.06666666666666674,"nameEN":"ALGORAE PHARMACEUTICALS LTD","floatShares":1046585658,"shares":1700498089,"eps":-0.000607,"marketStatus":"交易中","change":0.001,"latestTime":"03-24 10:49:50 AEDT","open":0.015,"high":0.016,"low":0.015,"amount":18040,"amplitude":0.066667,"askPrice":0.017,"askSize":715666,"bidPrice":0.016,"bidSize":19223,"shortable":3,"etf":0,"ttmEps":-0.000607,"tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1774328400000},"marketStatusCode":2,"adr":0,"exchange":"ASX","adjPreClose":0.015,"openAndCloseTimeList":[[1774306800000,1774328400000]],"volumeRatio":8.507351,"lotSize":1,"tradeCurrency":"AUD","auctionPricing":{"symbol":"1AI.AU","preClose":0.015,"auctionPrice":0.015,"auctionVolume":57725,"auction":3,"marketStatus":"盘后竞价","timestamp":1774242599189}},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"1AI.AU\",,,,,undefined,":{"symbol":"1AI.AU","floatShares":1046585658,"roa":"-39.62%","roe":"-47.38%","lyrEps":-0.000499,"volumeRatio":8.507351,"shares":1700498089,"dividePrice":0,"high":0.016,"amplitude":0.066667,"preClose":0.015,"low":0.015,"week52Low":0.005,"pbRate":"14.40","psRate":"-1040.10","week52High":0.024,"institutionHeld":0,"latestPrice":0.016,"committee":-0.947685,"eps":-0.000607,"divideRate":0,"volume":1180920,"delay":0,"ttmEps":-0.000607,"open":0.015,"prevYearClose":0.014,"prevWeekClose":0.015,"prevMonthClose":0.017,"prevQuarterClose":0.014,"fiveDayClose":0.015,"twentyDayClose":0.018,"sixtyDayClose":0.014,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/1AI.AU\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"1AI.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"1AI.AU\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1199700351","title":"Algorae制药公司达成协议 将在澳大利亚和新西兰推出两款心血管及代谢疾病仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=1199700351","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199700351?lang=zh_cn&edition=fundamental","pubTime":"2026-02-09 06:04","pubTimestamp":1770588254,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals Ltd宣布已签署一项重要合作协议，计划在澳大利亚与新西兰市场同步上市两款针对心血管疾病和代谢紊乱的通用名药物。\n此次战略布局将显著提升该公司在大洋洲医药市场的竞争力，通过提供高性价比的替代治疗方案，有望缓解当地患者长期用药的经济压力。两款药物的上市也将进一步完善Algorae在慢性病治疗领域的产品矩阵。\n业内人士分析，此次合作将加速仿制药在澳新地区的市场渗透，为Algorae拓展亚太区域业务奠定坚实基础。随着人口老龄化趋势加剧，心血管与代谢疾病药物市场需求持续增长，此举契合区域医疗健康产业的发展方向。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AI.AU","BK7067"],"gpt_icon":0},{"id":"1125866279","title":"Algorae Pharmaceuticals - 签署协议向澳大利亚市场供应化疗药物卡培他滨","url":"https://stock-news.laohu8.com/highlight/detail?id=1125866279","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125866279?lang=zh_cn&edition=fundamental","pubTime":"2025-11-27 06:01","pubTimestamp":1764194483,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals - 签署协议向澳大利亚市场供应化疗药物卡培他滨","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["1AI.AU","BK7067"],"gpt_icon":0},{"id":"1150849384","title":"Algorae Pharmaceuticals - 拟议协议下，公司将在澳新市场推出两款仿制药及其他产品","url":"https://stock-news.laohu8.com/highlight/detail?id=1150849384","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1150849384?lang=zh_cn&edition=fundamental","pubTime":"2025-10-20 06:01","pubTimestamp":1760911268,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals - 拟议协议下，公司将在澳新市场推出两款仿制药及其他产品","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0},{"id":"1163905870","title":"Algorae Pharmaceuticals达成协议，将5款仿制肿瘤药物推向澳大利亚和新西兰市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1163905870","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1163905870?lang=zh_cn&edition=fundamental","pubTime":"2025-09-23 06:55","pubTimestamp":1758581719,"startTime":"0","endTime":"0","summary":"Algorae Pharmaceuticals达成协议，将5款仿制肿瘤药物推向澳大利亚和新西兰市场","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK7067","1AI.AU"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":4,"code":"91000000","status":"200"}]}}